HK$
1.76
Sep 13
New Key Statistics Module, Z-Score and F-Score
HKSE:01349 Key Ratios
Market Cap HK$ M | 5,829.21 |
Enterprise Value HK$ M | 4,438.15 |
P/E(ttm) | 15.30 |
PE Ratio without NRI | 12.22 |
Forward PE Ratio | -- |
Price/Book | 0.72 |
Price/Sales | 2.27 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 44.00 |
Payout Ratio % | 0.53 |
Revenue (TTM) HK$ M | 795.00 |
EPS (TTM) HK$ | 0.12 |
Beneish M-Score | -2.26 |
10-y EBITDA Growth Rate % | 2.40 |
5-y EBITDA Growth Rate % | -5.30 |
y-y EBITDA Growth Rate % | -64.80 |
EV-to-EBIT | 38.47 |
EV-to-EBITDA | 38.47 |
PEG | -- |
Shares Outstanding M | 1,043.00 |
Net Margin (%) | 15.01 |
Operating Margin % | 19.81 |
Pre-tax Margin (%) | 14.40 |
Quick Ratio | 3.77 |
Current Ratio | 3.88 |
ROA % (ttm) | 3.79 |
ROE % (ttm) | 4.69 |
ROIC % (ttm) | 12.67 |
Dividend Yield % | 5.60 |
Altman Z-Score | 7.90 |
HKSE:01349 Number of Guru Trades
HKSE:01349 Volume of Guru Trades
Gurus Latest Trades with HKSE:01349
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:01349 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Insider Transactions
No Available Data